Rogaine's Hair Regrowth Promise Comes With Hidden Risks and Side Effects

Rogaine, known by its generic name minoxidil, is the only FDA-approved topical treatment for regrowing hair in androgenetic alopecia. This condition, often called male or female pattern hair loss, affects about half of people by the age of 50. While the treatment is widely used, it can come with side effects and risks. Female pattern hair loss, or FPHL, is primarily linked to genetics and hormonal changes. It becomes more common after menopause as oestrogen levels drop. Rogaine helps combat this by stimulating hair regrowth, but it is not without potential issues.

Users may experience temporary hair loss, known as minoxidil-induced telogen effluvium, within 2 to 8 weeks of starting treatment. This shedding typically lasts between 1.5 to 2 months. More commonly, contact dermatitis occurs, leading to itchiness, redness, flaking, irritation, or a burning sensation on the scalp.

Other side effects include unwanted facial hair growth if the medication touches the skin. Some people report scalp discomfort or unexpected hair growth elsewhere. Rogaine may also cause or worsen chest pain, increase heart rate, or exacerbate existing heart problems, leading to poor heart function.

The medication is classified as a category C drug during pregnancy. Nursing women are advised to avoid it due to potential harm to fetuses and young children. Rogaine offers a proven solution for hair regrowth in pattern hair loss. However, its use requires caution due to possible side effects and health risks. Patients should consult a healthcare provider before starting treatment, especially if they have heart conditions or are pregnant or breastfeeding.